一、交易经过详细梳理1. 初期报价与竞争开启2025年9月22日:辉瑞首次宣布以最高73亿美元收购Metsera(每股47.50美元现金,加最高22.50美元里程碑付款),较Metsera此前收盘价溢价42.5%。这是辉瑞自新冠疫情后规模最大的战略投资,旨在弥补其在减肥药领域的研发短板。2025年10月25日:诺和诺德突然介入,提出价值高达85亿美元的收购要约(每股56.5美元现金,叠加里程碑付款...
Source Link一、交易经过详细梳理1. 初期报价与竞争开启2025年9月22日:辉瑞首次宣布以最高73亿美元收购Metsera(每股47.50美元现金,加最高22.50美元里程碑付款),较Metsera此前收盘价溢价42.5%。这是辉瑞自新冠疫情后规模最大的战略投资,旨在弥补其在减肥药领域的研发短板。2025年10月25日:诺和诺德突然介入,提出价值高达85亿美元的收购要约(每股56.5美元现金,叠加里程碑付款...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.